Page last updated: 2024-08-24

gemcitabine and ubenimex

gemcitabine has been researched along with ubenimex in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1
Hou, J; Huang, Y; Jiang, Y; Li, X; Wang, X; Wu, J; Xu, W; Zhang, J; Zhang, Y	1

Other Studies

2 other study(ies) available for gemcitabine and ubenimex

Article	Year
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013
Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity. Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta, Thoracic; Apoptosis; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Discovery; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; Leucine; Molecular Structure; Rats; Structure-Activity Relationship; Swine	2016

Article

Year

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013

Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.

Bioorganic & medicinal chemistry, 2016, 11-15, Volume: 24, Issue:22

Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aorta, Thoracic; Apoptosis; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Discovery; Gemcitabine; Human Umbilical Vein Endothelial Cells; Humans; Leucine; Molecular Structure; Rats; Structure-Activity Relationship; Swine

2016